SARAH GOMEZ: Open Payments
NPI 1003425604 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 92 payments from 22 companies in 2025. Trend: 2023 $1,317 · 2024 $1,929 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $293 |
| AstraZeneca Pharmaceuticals LP | 6 | $194 |
| Lilly USA, LLC | 10 | $186 |
| Amgen Inc. | 10 | $147 |
| Novo Nordisk Inc | 8 | $144 |
| Vanda Pharmaceuticals Inc. | 9 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
Products named: VRAYLAR, MOUNJARO, FANAPT, Wegovy, REXULTI, FARXIGA, CAPLYTA, JARDIANCE.
Industry payments across FL — which companies pay providers there.
